TY - JOUR
T1 - Chronic kidney disease and incident cancer risk
T2 - an individual participant data meta-analysis
AU - Mok, Yejin
AU - Surapaneni, Aditya
AU - Sang, Yingying
AU - Coresh, Josef
AU - Grams, Morgan E.
AU - Matsushita, Kunihiro
AU - Ballew, Shoshana H.
AU - Alencar de Pinho, Natalia
AU - Ärnlöv, Johan
AU - Barreto, Sandhi M.
AU - Bell, Samira
AU - Brenner, Hermann
AU - Carrero, Juan Jesus
AU - Chinnadurai, Rajkumar
AU - Ciemins, Elizabeth
AU - Gansevoort, Ron T.
AU - Jassal, Simerjot K.
AU - Jung, Keum Ji
AU - Kirchner, H. Lester
AU - Konta, Tsuneo
AU - Kovesdy, Csaba P.
AU - Pandit, Krutika
AU - Luo, Li
AU - Rahman, Mahboob
AU - Robinson-Cohen, Cassianne
AU - Sabanayagam, Charumathi
AU - Schultheiss, Ulla T.
AU - Shlipak, Michael
AU - Staplin, Natalie
AU - Tonelli, Marcello
AU - Wang, Angela Yee Moon
AU - Woodward, Mark
AU - Wen, Chi Pang
AU - Lees, Jennifer S.
N1 - Copyright © 2025. The Author(s).
PY - 2025/11/30
Y1 - 2025/11/30
N2 - BACKGROUND: Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results. METHODS: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure. RESULTS: Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis. DISCUSSION: Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.
AB - BACKGROUND: Studies examining the association of chronic kidney disease (CKD) with cancer risk have demonstrated conflicting results. METHODS: This was an individual participant data meta-analysis including 54 international cohorts contributing to the CKD Prognosis Consortium. Included cohorts had data on albuminuria [urine albumin-to-creatinine ratio (ACR)], estimated glomerular filtration rate (eGFR), overall and site-specific cancer incidence, and established risk factors for cancer. Included participants were aged 18 years or older, without previous cancer or kidney failure. RESULTS: Among 1,319,308 individuals, the incidence rate of overall cancer was 17.3 per 1000 person-years. Higher ACR was positively associated with cancer risk [adjusted hazard ratio 1.08 (95% CI 1.06-1.10) per 8-fold increase in ACR]. No association of eGFR with overall cancer risk was seen. For site-specific cancers, lower eGFR was associated with urological cancer and multiple myeloma, whereas higher ACR was associated with many cancer types (kidney, head/neck, colorectal, liver, pancreas, bile duct, stomach, larynx, lung, hemolymphatic, leukaemia, and multiple myeloma). Results were similar in a 1-year landmark analysis. DISCUSSION: Albuminuria, but not necessarily eGFR, was independently associated with the subsequent risk of cancer. Our results warrant an investigation into mechanisms that explain the link between albuminuria and cancer.
UR - https://www.scopus.com/pages/publications/105021352805
U2 - 10.1038/s41416-025-03140-z
DO - 10.1038/s41416-025-03140-z
M3 - Article
C2 - 40914744
AN - SCOPUS:105021352805
SN - 0007-0920
VL - 133
SP - 1535
EP - 1543
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 10
ER -